Polvi A, Arranz E, Fernandez-Arquero M, Collin P, Mäki M, Sanz A, Calvo C, Maluenda C, Westman P, de la Concha E G, Partanen J
Tissue Typing Laboratory, FRC Blood Transfusion Service, Helsinki, Finland.
Hum Immunol. 1998 Mar;59(3):169-75. doi: 10.1016/s0198-8859(98)00008-1.
Genetic susceptibility to celiac disease (CD) is strongly associated with DQA10501 and DQB102 (= DQ2). To study whether CD patients without DQ2 share other MHC class II or TNF alleles, we screened DQ2-negative patients in Finland and Spain. Twelve of 84 (14%) Finnish patients and 13 of 189 (6%) Spanish patients were negative for DQ2. We observed that all but two of altogether 25 DQ2-negative patients had the DR4 DQ8 haplotype, or either DQA10501 or DQB102 alone. Also, all but three were positive for DRB401. The only patients without any of these alleles were both positive for DR 13. There was a clear difference between Finland and Spain: Ten (83%) of the 12 Finnish DQ2-negative patients but only five (38%) of the 13 Spanish patients had DRB103, DQA103, DQB10302 (= DQ8) alleles. Of the Spanish patients, eight (62%) had DQB102 without DQA10501 and three (23%) had DQA10501 without DQB102. None of the TNF, TAP, or DPB1 alleles was found to be significantly associated with CD. Our results indicate that in addition to the DQ2 heterodimer, the other major risk alleles for CD are DR4 DQ8, and either DQA10501 or DQB102 alone. Patients without these alleles appear to be very rare, only two (0.7%) were identified in altogether 253 patients tested.
乳糜泻(CD)的遗传易感性与DQA10501和DQB102(= DQ2)密切相关。为了研究无DQ2的CD患者是否共享其他MHC II类或TNF等位基因,我们对芬兰和西班牙的DQ2阴性患者进行了筛查。84名芬兰患者中有12名(14%)、189名西班牙患者中有13名(6%)DQ2呈阴性。我们观察到,在总共25名DQ2阴性患者中,除两名外,其余均具有DR4 DQ8单倍型,或单独具有DQA10501或DQB102。此外,除三名外,其余均为DRB401阳性。唯一没有这些等位基因的患者DR 13均为阳性。芬兰和西班牙之间存在明显差异:12名芬兰DQ2阴性患者中有10名(83%)具有DRB103、DQA103、DQB10302(= DQ8)等位基因,而13名西班牙患者中只有5名(38%)具有这些等位基因。在西班牙患者中,8名(62%)具有无DQA10501的DQB102,3名(23%)具有无DQB102的DQA10501。未发现TNF、TAP或DPB1等位基因与CD有显著关联。我们的结果表明,除了DQ2异二聚体之外,CD的其他主要风险等位基因为DR4 DQ8,以及单独的DQA10501或DQB102。没有这些等位基因的患者似乎非常罕见,在总共253名接受检测的患者中仅发现两名(0.7%)。